SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eason Technology Ltd. engages in the provision of loan facilities to micro, small and medium size enterprises, and sole proprietors. It also offers microfinance lending services. The company was founded by Qi Ming Xu and Kang Kai Zeng on June 24, 2010 and is headquartered in Wuhan, China.

Eason Technology Ltd. - ADR

Eason Technology Ltd ADR

Eason Technology ($DXF) is trending as traders discuss its ultra-low float and potential for a significant price surge, drawing comparisons to other low-float stocks that have recently experienced substantial gains. Community members are anticipating news related to compliance and potential blockchain ventures as possible catalysts. Some traders note the stock's history of volatile runs, while others point to potential over-shorting as a squeeze setup.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as the community debates whether the stock is overvalued, with some pointing to its lack of revenue and insider selling, while others cite its potential in the nuclear energy sector and government backing. Discussions also involve potential offerings and comparisons to other companies in the space, such as $SMR. The stock's volatile price action and resilience in a down market are fueling the conversation.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending amid speculation and reports of a potential investment from Apple, fueling optimism about Intel's turnaround and closer collaboration between the tech giants. Community discussions revolve around potential price targets, the impact of government support and partnerships, and the possibility of Intel regaining its dominance in the chip industry. Some investors express caution, citing past volatility and potential for dilution, while others are bullish, anticipating further gains and long-term growth.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure (QURE) is trending after announcing positive results in its Huntington's disease gene therapy trial, AMT-130, showcasing a significant slowing of disease progression. Community discussions revolve around the potential for a major breakthrough in treating this devastating condition, with some cautioning about potential dilutions. Others are focused on comparing QURE to similar companies.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors discuss upcoming NASA news and potential contract awards, especially for the Lunar Terrain Vehicle (LTV). Community members are weighing the impact of these catalysts against technical indicators, with some pointing to bullish formations while others remain bearish. The company's existing NASA contracts and potential for expansion in lunar infrastructure are also key talking points.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

IMRX is trending following the announcement of extraordinary survival data in a Phase 2a trial for pancreatic cancer treatment, leading to a surge of community discussion. Bullish investors are particularly enthusiastic due to positive survival data and an existing collaboration with Lilly. However, a proposed public offering is tempering immediate gains as the community assesses its potential impact.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as it rides the wave of hype surrounding quantum computing, with the community actively debating whether the stock's valuation is justified given its current revenue. Some traders point to recent government contracts and grants as validation of the company's tech roadmap, while others caution about potential pullbacks and overextension. The stock's momentum is also fueled by a potential short squeeze.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors discuss potential ticker suppression and speculation about unusual ticker behavior before earnings. The community is focused on the company's upcoming earnings report and long-term revenue streams solidifying. Some investors believe this suppression is temporary and anticipate a significant move following the earnings report.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as investors react to news of increased AI spending and a potential partnership with Nvidia. The community is discussing the stock's recent surge and whether it can reach previous highs, with some eyeing $200 as the next target. Broader conversations include the AI race between the U.S. and China, with some considering BABA as a key player in the sector.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending as community members spread the word and ask, 'What's Updog?', referencing the popular meme. Built on Solana and listed on $JUP.X, the community emphasizes its strong, long-term foundation and encourages others to load their $SOL.X clips.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alpha Tau Medical Ltd. shares hit their highest level on Monday in three months following the company's report of a smaller-than-expected quarterly loss and advances in several U.S. FDA-approved clinical trials.The stock rose 11.1% to close at $3.10 and extended gains by another 6.5% to $3.30 in after-hours trading.For the first quarter ending March 31, the company posted a net loss of $8.7 million, equivalent to $0.12 per share,&nbsp;widening from a loss of $8.0 million or $0.11 per share&nbsp;a year earlier.According to The Fly, analysts expected Alpha Tau Medical to report a&nbsp;bigger loss of $0.13 per share.The company's financial income rose to $0.7 million from $0.4 million in the previous year due to reduced warrant remeasurement expenses,&nbsp;offsetting the decrease in interest income from deposits.Alpha Tau's regulatory achievements, including four active FDA Investigational Device Exemptions (IDEs) and upcoming U.S. trials for pancreatic cancer along with recurrent glioblastoma multiforme (GBM), generated positive investor response, which led to share price increases even though financial losses continued.CEO Uzi Sofer said that 2025 started with significant milestones,&nbsp;such as facility expansion in New Hampshire and strong clinical advancements,&nbsp;which received support from a $36.9 million capital increase.On Stocktwits, retail sentiment was ‘bearish’ amid ‘high’ message volume.The stock has remained flat so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Israel-based biopharma reported positive final results from a randomized Phase 2 study of its lead oncology drug, CM24, in patients with pancreatic ductal adenocarcinoma.

Alpha Tau Stock Rallies To 3-Month High On Smaller-Than-Feared Q1 Loss: Retail Sentiment Stays Bearish

The company’s stock surged to a three-month high following its Q1 report, progress in FDA-approved clinical trials, and a recent capital raise.

Equity

Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit

JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the Company ) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT...

Alpha Tau Medical (DRTS, $3.04) Aroon Indicator entered a Downtrend on March 20, 2024.

For the last three days, A.I.dvisor has detected that DRTS's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Head-To-Head Comparison: Alpha Tau Medical (NASDAQ:DRTS) & Tactile Systems Technology (NASDAQ:TCMD)

Alpha Tau Medical (NASDAQ:DRTS  Get Free Report) and Tactile Systems Technology (NASDAQ:TCMD  Get Free Report) are both small-cap medical companies, but which is the better investment...

Alpha Tau Medical Ltd (DRTS) Gets a Buy from Piper Sandler

Piper Sandler analyst Jason Bednar reiterated a Buy rating on Alpha Tau Medical Ltd (DRTS Research Report) today and set a price target of $7.00...

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

- Positive interim safety and feasibility data from pancreatic cancer study in Montreal, with initial signs of potential dose response findings - - ReSTART U.S. multi-center pivotal trial currently...

Alpha Tau Medical (NASDAQ:DRTS) vs. Profound Medical (NASDAQ:PROF) Head-To-Head Contrast

Profound Medical (NASDAQ:PROF  Get Free Report) and Alpha Tau Medical (NASDAQ:DRTS  Get Free Report) are both small-cap medical companies, but which is the better business? We will...

Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference

JERUSALEM, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the Company ) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT...

Reviewing Todos Medical (OTCMKTS:TOMDF) and Alpha Tau Medical (NASDAQ:DRTS)

Todos Medical (OTCMKTS:TOMDF  Get Free Report) and Alpha Tau Medical (NASDAQ:DRTS  Get Free Report) are both small-cap medical companies, but which is the superior investment? We will...

Individual investors who hold 58% of Alpha Tau Medical Ltd. (NASDAQ:DRTS) gained 11%, insiders profited as well

Key Insights Significant control over Alpha Tau Medical by individual investors implies that the general public has...

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

Will Costco Wholesale ($COST) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

DRTS
ALPHA TAU MEDICAL LTD

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DRTS News

DRTS ALPHA TAU MEDICAL LTD